Literature DB >> 21166592

The role of protein kinase R in the interferon response.

Agnieszka Pindel1, Anthony Sadler.   

Abstract

The effects of interferons (IFNs) are mediated through the induction of around 2,000 IFN-stimulated gene (ISG) products. However, the majority of these ISGs do not directly instigate IFN-mediated states, such as the defining resistance to viral infection. Rather, most ISGs encode cell signaling molecules that enhance the responsiveness to pathogens, and systemically disseminate signals from localized sites of infection. Relatively few IFN effector proteins have been well characterized. The protein kinase R (PKR) is one of the first and best characterized of these effector molecules. PKR mediates responses via phosphorylation of protein substrates and promotes signal transduction pathways to maintain homeostasis, mediate immune responses, and, upon sustained activation, promote apoptosis. As a number of reviews have dealt with PKR-dependent resistance to virus, this review will cover broader roles ascribed to PKR and the mechanism(s) by which PKR exerts its effects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21166592     DOI: 10.1089/jir.2010.0099

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  78 in total

1.  Regulation of PKR by RNA: formation of active and inactive dimers.

Authors:  Bushra Husain; Stephen Hesler; James L Cole
Journal:  Biochemistry       Date:  2015-10-26       Impact factor: 3.162

Review 2.  ADARs: viruses and innate immunity.

Authors:  Charles E Samuel
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

3.  Protein kinase PKR catalytic activity is required for the PKR-dependent activation of mitogen-activated protein kinases and amplification of interferon beta induction following virus infection.

Authors:  Nora Taghavi; Charles E Samuel
Journal:  Virology       Date:  2012-03-03       Impact factor: 3.616

4.  Monitoring activation of the antiviral pattern recognition receptors RIG-I and PKR by limited protease digestion and native PAGE.

Authors:  Michaela Weber; Friedemann Weber
Journal:  J Vis Exp       Date:  2014-07-29       Impact factor: 1.355

Review 5.  Molecular Mechanisms of Innate Immune Inhibition by Non-Segmented Negative-Sense RNA Viruses.

Authors:  Srirupa Chatterjee; Christopher F Basler; Gaya K Amarasinghe; Daisy W Leung
Journal:  J Mol Biol       Date:  2016-07-31       Impact factor: 5.469

6.  The Ambystoma tigrinum virus (ATV) RNase III gene can modulate host PKR activation and interferon production.

Authors:  Alexander G Allen; Scott Morgans; Eric Smith; Mariah M Aron; James K Jancovich
Journal:  Virology       Date:  2017-08-23       Impact factor: 3.616

7.  Japanese encephalitis virus core protein inhibits stress granule formation through an interaction with Caprin-1 and facilitates viral propagation.

Authors:  Hiroshi Katoh; Toru Okamoto; Takasuke Fukuhara; Hiroto Kambara; Eiji Morita; Yoshio Mori; Wataru Kamitani; Yoshiharu Matsuura
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

8.  Type I Interferons Act Directly on Nociceptors to Produce Pain Sensitization: Implications for Viral Infection-Induced Pain.

Authors:  Paulino Barragán-Iglesias; Úrzula Franco-Enzástiga; Vivekanand Jeevakumar; Stephanie Shiers; Andi Wangzhou; Vinicio Granados-Soto; Zachary T Campbell; Gregory Dussor; Theodore J Price
Journal:  J Neurosci       Date:  2020-04-03       Impact factor: 6.167

9.  Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses.

Authors:  S Bhattacharya; W-C HuangFu; G Dong; J Qian; D P Baker; J Karar; C Koumenis; J A Diehl; S Y Fuchs
Journal:  Oncogene       Date:  2012-10-08       Impact factor: 9.867

10.  RNA-dependent protein kinase PKR and the Z-DNA binding orthologue PKZ differ in their capacity to mediate initiation factor eIF2α-dependent inhibition of protein synthesis and virus-induced stress granule formation.

Authors:  Nora Taghavi; Charles E Samuel
Journal:  Virology       Date:  2013-05-23       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.